Interaction of BMP10 with Tcap may modulate the course of hypertensive cardiac hypertrophy

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 293, Issue 6, 2007, Pages

  Nakano, Noritsugu ^a   Hori, Hisae ^a   Abe, Minako ^a   Shibata, Hiroki ^a   Arimura, Takuro ^a   Sasaoka, Taishi ^a,b   Sawabe, Motoji ^c   Chida, Kouji ^c   Arai, Tomio ^c   Nakahara, Ken Ichi ^d   Kubo, Toru ^e   Sugimoto, Ken ^f   Katsuya, Tomohiro ^f   Ogihara, Toshio ^f   Doi, Yoshinori ^e   Izumi, Tohru ^b   Kimura, Akinori ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c Tokyo Metropolitan Institute of Gerontology   (Japan)

^d NATIONAL HOSPITAL ORGANIZATION NAGASAKI MEDICAL CENTER   (Japan)

^e KOCHI MEDICAL SCHOOL   (Japan)

^f OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Bone morphogenetic protein 10; Cardiomyopathy; Wall stress; Z disc

Indexed keywords

ADAPTOR PROTEIN; BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 10; PROTEIN TCAP; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; GENETIC VARIABILITY; HEART FUNCTION; HEART MUSCLE CELL; HEART VENTRICLE HYPERTROPHY; HYPERTENSION; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; IMMUNOPRECIPITATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WALL STRESS;

ANIMALS; ANIMALS, NEWBORN; AUTOCRINE COMMUNICATION; BONE MORPHOGENETIC PROTEINS; CARDIOMEGALY; CELL SIZE; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; HUMANS; HYPERTENSION; MUSCLE PROTEINS; MUTATION; MYOCYTES, CARDIAC; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROTEIN BINDING; RATS; RATS, INBRED SHR; RATS, SPRAGUE-DAWLEY; SODIUM CHLORIDE, DIETARY; TIME FACTORS; TRANSFECTION; UP-REGULATION;

EID: 36849043778     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00311.2007     Document Type: Article

References (33)

1. Aoki H, Izumo S, Sadoshima J. Angiotenin II activates RhoA in cardiac myocytes - a critical role of RhoA in angiotensin II-induced premyofibril formation. Circ Res 82: 666-676, 1998.
2. Arimura T, Hayashi T, Terada H, Lee SY, Zhou Q, Takahashi M, Ueda K, Nouchi T, Hohda S, Shibutani M, Hirose M, Chen J, Park JE, Yasunami M, Hayashi H, Kimura A. A Cypher/ZASP mutation associated with dilated cardiomyopathy alters the binding affinity to protein kinase C. J Biol Chem 279: 6746-6752, 2004.
3. Brown MA, Zhao Q, Baker KA, Naik C, Chen C, Pukac L, Singh M, Tsareva T, Parice Y, Mahoney A, Roschke V, Sanyal I, Choe S. Crystal structure of BMP9 and functional interactions with pro-region and receptors. J Biol Chem 280: 25111-25118, 2005.
4. Chen H, Shi S, Acosta L, Li W, Lu J, Bao S, Chen Z, Yang Z, Schneider MD, Chien KR, Conway SJ, Yoder MC, Haneline LS, Franco D, Shou W. BMP10 is essential for maintaining cardiac growth during murine cardiogenesis. Development 131: 2219-2231, 2004.
5. Chen H, Yong W, Ren S, Shen W, He Y, Cox KA, Zhu W, Li W, Soonpaa M, Payne MR, Franco D, Field LJ, Rosen V, Wang Y, Shou W. Overexpression of bone morphogenetic protein 10 in myocardium disrupts cardiac postnatal hypertrophic growth. J Biol Chem 281: 27481-27491, 2006.
6. Danser AH, Schalekamp MA, Bax WA, van den Brink AM, Saxena PR, Riegger GA, Schunkert H. Angiotensin-converting enzyme in the human heart. Effect of the deletion/insertion polymorphism. Circulation 92: 1387-1388, 1995.
7. Du A, Sanger JM, Linask KK, Sanger JW. Myofibrinogenesis in the first cardiomyocytes formed from isolated quail precardiac mesoderm. Dev Biol 257: 382-394, 2003.
8. Furukawa T, Ono Y, Tsuchiya H, Katayama Y, Bang ML, Labeit D, Labeit S, Inagaki N, Gregorio CC. Specific interaction of potassium channel b-subunit minK with sarcomere protein Tcap suggests a T-tubule-myofibril linking system. J Mol Biol 313: 775-784, 2001.
9. Ge G, Hopkins DR, Ho WB, Greenspan DS. GDF11 forms a bone morphogenetic protein 1-activated latent complex that can modulate nerve growth factor-induced differentiation of PC12 cells. Mol Cell Biol 14: 5846-5858, 2005.
10. 2 terminus of Titin spans the Z-disc: interaction with novel 19-kD ligand (Tcap) is required for sarcomere integrity. J Cell Biol 16: 1013-1027, 1998.
11. Hayashi T, Arimura T, Itoh-Satoh M, Ueda K, Hohda S, Inagaki N, Takahashi M, Hori H, Yasunami M, Nishi H, Koga Y, Nakamura H, Matsuzaki M, Choi BY, Bae SW, You CW, Han KH, Park JE, Knoll R, Hoshijima M, Chien KR, Kimura A. Tcap gene mutations in hypertrophic cardiomyopathy and dilated cardiomyopathy. J Am Coll Cardiol 44: 2191-2201, 2004.
12. Ho KI, Anderson KM, Kannel WB, Grossman W, Levy D. Survival after the onset of congestive heart failure in Framingham Heart Study subjects. Circulation 88: 107-115, 1993.
13. Imai Y, Matsushima N, Sugimura T, Terada M. A simple and rapid method for generating a deletion by PCR. Nucleic Acids Res 19: 2785-2785, 1991.
14. Inoko M, Kihara Y, Morii I, Fujiwawa H, Sasayama S. Transition from compensatory hypertrophy to dilated, failing left ventricles in Dahl salt-sensitive rats. Am J Physiol Heart Circ Physiol 267: H2471-H2482, 1994.
15. Kimura A, Harada H, Park JE, Nishi H, Satoh M, Takahashi M, Hiroi S, Sasaoka T, Ohbuchi N, Nakamura T, Koyanagi T, Hwang TH, Choo JA, Chung KS, Hasegawa A, Nagai R, Matsuzaki M, Sakamoto T, Toshima H, Koga Y, Imaizumi T, Sasazuki T. Mutations in the cardiac troponin I gene associated with hypertrophic cardiomyopathy. Nat Genet 16: 379-382, 1997.
16. Knoll R, Hoshijima M, Hoffman HM, Person V, Lorenzen-Schmidt I, Bang ML, Hayashi T, Shiga N, Yasukawa H, Schaper W, McKenna W, Yokoyama M, Schork NJ, Omens JH, McCulloch AD, Kimura A, Gregorio CC, Poller W, Schaper J, Schultheiss HP, Chien KR. The cardiac mechanical stretch sensor machinery involves a Z disc complex that is defective in a subset of human dilated cardiomyopathy. Cell 111: 943-955, 2002.
17. Komajda M. Genetics of dilated cardiomyopathy: a molecular maze? Heart 84: 463-464, 2000.
18. Lee KW, Liu B, Ma L, Li H, Bang P, Koeffler HP, Cohen P. Cellular localization of insulin-like growth factor binding protein-3, distinct endocytic pathways facilitate re-uptake and nuclear localization. J Biol Chem 279: 469-476, 2004.
19. McMullen JR, Shioi T, Zhang L, Tarnavski O, Sherwood MC, Kang PM, Izumo S. Phosphoinositide 3-kinase(p110a) plays a critical role for the induction of physiological, but not pathological, cardiac hypertrophy. Proc Natl Acad Sci USA 100: 12355-12360, 2003.
20. Nakagawa O, Ogawa Y, Itoh H, Suga S, Komatsu Y, Kishimoto I, Nishio K, Yoshimasa T, Nakao K. Rapid transcriptional activation of early mRNA turnover of BNP in cardiocyte hypertrophy. J Clin Invest 96: 1280-1287, 1995.
21. Nakahara K, Matsushita S, Matsuoka H, Inamatsu T, Nishinaga M, Yonawa M, Aono T, Arai T, Ezaki Y, Orimo H. Insertion/deletion polymorphism in the angiotensin-converting enzyme gene affects heart weight. Circulation 101: 148-151, 2000.
22. Neuhaus H, Rosen V, Thies R. Heart specific expression of mouse BMP-10, a novel member of the TGF-beta superfamily. Mech Dev 80: 181-184, 1999.
23. Nicholas G, Thomas M, Langley B, Somers W, Patel K, Kemp CF, Sharma M, Kambadur R. Titin-cap associates with, and regulates secretion of, myostatin. J Cell Physiol 193: 120-131, 2002.
24. Ohkawara B, Iemura SI, tenDijke P, Ueno N. Action range of BMP is defined by its N-terminal basic acid core. Curr Biol 12: 205-209, 2002.
25. Pashmforoush M, Lu JT, Chen H, Amand TS, Kondo R, Pradevand S, Evans SM, Clark B, Feramisco JR, Giles W, Ho SY, Benson DW, Silberbach M, Show W, Chien KR. Nkx2.5 pathways and congenital heart disease: loss of ventricular myocyte lineage specification leads to progressive cardiomyopathy and complete heart block. Cell 117: 373-386, 2004.
26. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 86: 1343-1346, 1990.
27. Sadoshima J, Izumo S. The cellular and molecular response of cardiac myocytes to mechanical stress. Annu Rev Physiol 59: 551-571, 1997.
28. Schuelke M, Wagner KR, Stolz LE, Hubner C, Riebel T, Komen W, Braun T, Tobin JF, Lee SJ. Myostatin mutation associated with gross muscle hypertrophy in a child. N Engl J Med 350: 2682-2688, 2004.
29. Schut AF, Bleumink GS, Stricker BH, Hofman A, Witteman JC, Pols HA, Deckers JW, Deinum J, van Duijin CM. Angiotensin converting enzyme insertion/deletion polymorphism and the risk of heart failure in hypertensive subjects. Eur Heart J 25: 2143-2148, 2004.
30. Shou W, Aghdasi B, Armstrong DL, Guo Q, Bao S, Charng MJ, Mathews LM, Schneider MD, Hamilton SL, Matzuk MM. Cardiac defects and altered ryanodine receptor function in micel lacking FKBP12. Nature 391: 489-492, 1998.
31. Teichmann U, Kessel M. Highly restricted BMP10 expression in the trabeculating myocardium of the chick embryo. Dev Genes Evol 214: 96-98, 2004.
32. Wolfman NM, McPherron AC, Pappano WN, Davies MV, Kening S, Tomkinson KN, Wright JF, Zhao L, Sebald SM, Greenspan DS, Lee SJ. Activation of latent myostatin by BMP1/Tolloid family metalloproteinases. Proc Natl Acad Sci USA 100: 15842-15846, 2003.
33. Yamazaki T, Komuro I, Shiojima I, Yazaki Y. The molecular mechanism of cardiac hypertrophy and failure. Ann NY Acad Sci 874: 38-48, 1999.